[1]
“Challenging management of severe differentiation syndrome in pediatric acute promyelocytic leukemia treated with ATRA/ATO”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022027, Feb. 2022, doi: 10.4084/MJHID.2022.027.